Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
This is an exciting opportunity for a highly analytical and strategic individual to join our team as a Director/Sr. Director of Early Pipeline Commercialization. This role is critical in shaping the future success of our pipeline by providing market-driven insights to inform portfolio prioritization, indication selection, and strategic positioning. You will work cross-functionally with R&D, regulatory, corporate strategy and commercial teams to ensure seamless integration of scientific innovation with market needs. This is a high-impact, high-visibility role with a unique opportunity to lead in an entrepreneurial environment and affect the trajectory of the company’s first launch.